#Ervebo
Congo to receive 70,000 doses of Canadian developed Ervebo Ebola vaccine which has been effective in past outbreaks

www.ctvnews.ca/world/articl...
Congo to receive 70,000 doses of Ervebo Ebola vaccine which has been effective in past outbreaks
Congo will receive 70,000 doses of the Ervebo vaccine, which has been effective in past Ebola outbreaks, the World Health Organization (WHO) and partners said Thursday, announcing a step seen as a maj...
www.ctvnews.ca
August 20, 2026 at 4:21 PM
More than 16,000 doses of Ervebo vaccine arrive in Ebola-hit DR Congo https://aje.news/yt5c66
August 22, 2026 at 11:00 AM
DR Congo to receive 70,000 doses of Ervebo vaccine as Ebola infections surge https://aje.news/3jdnzl
August 21, 2026 at 1:30 AM
The WHO technical advisory group on vaccine research met last Friday to review new data on the Ervebo vaccine, the only licensed vaccine against Ebola virus disease.

Read more:
bit.ly/4fK9pch
August 7, 2026 at 4:26 PM
Congo will receive 70,000 doses of the Ervebo vaccine, which has been effective in past Ebola outbreaks, the WHO and partners said Thursday, announcing a step seen as a major boost to efforts to contain what officials have described as the fastest Ebola outbreak in history.https://to.pbs.org/4yd30wH
Congo to receive 70,000 doses of Ervebo Ebola vaccine, which was effective in past outbreaks
WHO said in a statement that while it’s not known whether Ervebo may protect against the Bundibugyo virus, “early laboratory and animal data suggest it may provide some protection.”
www.pbs.org
August 21, 2026 at 1:00 AM
The bits of animal data suggesting #Ervebo, the #Ebola Zaire vaccine, might be useful against #Bundibugyo Ebola are getting supported from data showing some cross protection in blood of vaccinees. That's leading to increasing calls to study the vaccine in DRC. www.statnews.com/2026/07/22/n...
New study supports testing of Merck’s Ebola vaccine in DRC outbreak
New data supports the idea that Merck’s Ebola vaccine Ervebo, licensed to target the Zaire species of ebolaviruses, could also offer some protection against another.
www.statnews.com
July 22, 2026 at 9:48 PM
The WHO announced in its press conference today an adaptive Ph3 trial that will evaluate Ervebo the Zaire virus targeting Eola vaccine for BDBV Ebola in the DRC. They plan and adaptive design with a ring vaccination approach.
www.clinicaltrialsarena.com/news/who-cal...
WHO calls for Phase III Ervebo vaccine trial amid Bundibugyo Ebola outbreak
In the absence of a vaccine candidate for the Bundibugyo, panellists agreed to investigate Ervebo against the strain.
www.clinicaltrialsarena.com
August 12, 2026 at 6:25 PM
#Ebolafieber: Weniger schwere Krankheitsverläufe durch die Impfung mit einem anderen Ebolavirus-Impfstoff?

Dazu haben wir eine groß angelegte Studie in der Demokratischen Republik Kongo gestartet.

20.000 medizinische Ersthelfende können sich nun freiwillig mit dem Impfstoff #ERVEBO impfen lassen.
Neue Studie untersucht Schutzwirkung von ERVEBO-Impfstoff gegen das Bundibugyo-Virus
Im Ostkongo breitet sich Ebola weiter aus. Eine Studie prüft nun, ob der Impfstoff ERVEBO auch vor dem Bundibugyo-Virus schützen kann.
www.aerzte-ohne-grenzen.de
September 21, 2026 at 1:15 PM
Since evidence remains insufficient to support the programmatic use of the Ervebo vaccine for the prevention of BDBV disease, WHO recommends Ervebo should only be used for BDBV within the context of a research protocol.

Read more: bit.ly/4cjzCMK

bsky.app/profile/who....
who.int WHO @who.int · Sep 2
WHO has issued new emergency guidance on the use of licensed Ebola vaccines during Bundibugyo virus disease (BDBV) outbreaks, following an Extraordinary Meeting of the Strategic Advisory Group of Experts on Immunization.

Read more: bit.ly/4cjzCMK
September 2, 2026 at 1:07 PM
Thousands of Ervebo vaccine doses arrive in Ebola-stricken Democratic Republic of the Congo
Thousands of Ervebo vaccine doses arrive in Ebola-stricken DRC
The Ervebo vaccine is most effective against the Zaire strain of the Ebola virus, however the WHO said it may provide some protection against the current Bundibugyo strain.
www.abc.net.au
August 22, 2026 at 12:29 PM
5/ The core challenge remains no approved vaccine and no approved therapeutics.
Every high-profile Ebola response since 2014 had Ervebo (for Zaire ebolavirus). Bundibugyo is a different species. Ervebo shows minimal cross-protection. We are near zero on licensed countermeasures.
May 23, 2026 at 11:26 AM
Ervebo the zaire Ebola vaccine is being rolled out in the context of a clinical trial in the DRC as efforts continue to contain the outbreak of Bundibugyo Ebola virus.
Here is an update on #Ebola in DR #Congo. The WHO has decided to trial an Ebola vaccine used in previous outbreaks. The decision comes following new evidence showing it might provide some protection despite being engineered to target a different virus strain.

www.forbes.com/sites/victor...
Ebola Vaccine Rollout Begins In DR Congo Amid Continuing Outbreak
The vaccine was not designed for the Bundibugyo strain causing the epidemic, but experts are hopeful that it may provide some protection while new vaccines are developed.
www.forbes.com
August 28, 2026 at 5:41 PM
Very feasible. In fact, we already have an Ebola vaccine Ervebo, which protects against Zaire ebolavirus. The issue is that “Ebola” is not one virus. Zaire, Sudan and Bundibugyo ebolaviruses are different enough that one vaccine may not protect well against all of them.
June 27, 2026 at 3:03 PM
Ervebo vaccine trial kicks off in Ebola-ravaged DRC

The vaccine targets Zaire strain of Ebola, but many hope there will be cross-protection against the Bundibugyo strain.

Read more: https://bit.ly/46BhSJm

📷: NIAID/Filckr cc
September 21, 2026 at 9:21 PM
🦠 Ebola Outbreak — Kasai, DRC (Sitrep 15 Sept 2025)

- 54 cases, 27 deaths, incl. 4 health workers
- Epicenter: Bulape & Mweka zones
- Vaccination with Ervebo underway for health workers & contacts
- WHO risk: High (national), Moderate (regional), Low (global)

iris.who.int/bitstream/ha...
September 17, 2025 at 2:18 AM
Given debate about vaccines, this matters 👇

🦠 #Ebola has a 25–90% fatality rate. I’ve personally seen hundreds die from this disease. Supportive care & vaccination are critical.

Vaccines:
- Ervebo: 1 dose, proven in outbreaks
- Zabdeno/Mvabea: 2 doses, broader protection

✅ Vaccines save lives.
September 4, 2025 at 2:56 PM
Congo to receive 70,000 doses of Ervebo Ebola vaccine which has been effective in past outbreaks apnews.com/article/cong...
Congo to receive 70,000 doses of Ervebo Ebola vaccine which has been effective in past outbreaks
The World Health Organization says Congo will receive 70,000 doses of the Ervebo vaccine. This move is seen as a major boost to efforts to contain what officials describe as the fastest Ebola outbreak...
apnews.com
August 20, 2026 at 2:14 PM
The Bundibugyo epidemic, ​the world's second-largest, has been described as the ⁠fastest-spreading on record.
Ebola cases top 4,000 in DRC as WHO urges Ervebo vaccine trial
The Bundibugyo epidemic, ​the world's second-largest, has been described as the ⁠fastest-spreading on record.
www.aljazeera.com
August 7, 2026 at 9:30 PM
☣️ DR Congo Expands Ervebo Vaccination Amid Record Ebola Death Toll ☣️ www.telesurenglish.net/dr-congo-erv...
According to the latest report from the Congolese National Public Health Institute, the ebola outbreak, since May, has already claimed 3700+ lives and infected 7600+ people
September 22, 2026 at 6:08 PM
Congo to receive 70,000 doses of Ervebo Ebola vaccine which has been effective in past outbreaks
Congo to receive 70,000 doses of Ervebo Ebola vaccine which has been effective in past outbreaks
www.chicagotribune.com
August 20, 2026 at 2:44 PM
Whether Ervebo protects humans against Bundibugyo virus remains unclear. Animal studies suggest Ervebo may provide partial cross-protection and could thus potentially help contain the current outbreak, but clinical data in humans are lacking. 2/2 #Ebola
May 25, 2026 at 7:57 PM
🆕 Data in @thelancetinfdis.bsky.social show Ervebo-induced antibodies cross-neutralize 2026 #Bundibugyo virus in vitro, though less potently than Ebola virus. Not proof of protection—but more evidence supporting evaluation of heterologous vaccine approaches.
www.thelancet.com/action/showP...
www.thelancet.com
July 24, 2026 at 4:23 AM
WHO urges Ervebo vaccine trial in DR Congo Ebola outbreak
https://www.youtube.com/watch?v=5WQ9a4pbo04
WHO urges Ervebo vaccine trial in DR Congo Ebola outbreak • FRANCE 24 English
YouTube video by FRANCE 24 English
www.youtube.com
August 10, 2026 at 3:18 PM